Vanberra Signal

U-Ploid Biotechnologies

Curated by Signal

Platform offering fertility therapeutics to address age related infertility

Overview

Platform offering fertility therapeutics to address age related infertility. It aims to enhance egg quality and is designed to seamlessly integrate with IVF protocols. It aims to repair the accumulated damage in older eggs, which is a significant factor affecting fertility outcomes for women who choose to start families later in life.

Key facts

Founded
2024

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Health Technology companies
  • Provider of mobile app for muscle health management

    Health TechnologyLondon, United Kingdom
  • Digital healthcare financial analytics platform for patients, providers, and payers

    Health TechnologyLondon, United Kingdom
  • Booking software for yoga and fitness classes

    Health TechnologyLondon, United Kingdom

About U-Ploid Biotechnologies

What does U-Ploid Biotechnologies do?

Platform offering fertility therapeutics to address age related infertility.

Where is U-Ploid Biotechnologies headquartered?

U-Ploid Biotechnologies is headquartered in London, United Kingdom.

When was U-Ploid Biotechnologies founded?

U-Ploid Biotechnologies was founded in 2024.

Which sector is U-Ploid Biotechnologies in?

U-Ploid Biotechnologies operates in Health Technology.

Who are U-Ploid Biotechnologies's competitors?

Companies similar to U-Ploid Biotechnologies include TrackActive Me, S Konsult, and InstaBook.